News

Nottingham, UK, and Welwyn Garden City, UK – 28th July 2015 Sygnature Discovery, a company which undertakes integrated drug discovery projects for pharmaceutical and biotechnology companies worldwide, and Essen BioScience Ltd., a world leader in the field of cell-based in vitro assays and instrumentation, today announced they have established into a strategic alliance. Under the […]

Sygnature Discovery is holding a careers event at the University of Oxford: Date: Thursday 2nd June 2015 Time: 6.00pm for 6.30pm Location: Chemistry Research Laboratory Rooms: The Atrium and Basement Seminar Room Come and join us for drinks and snacks to explore how you could play your part in Sygnature’s exciting future. […]

18th May 2015 – Nottingham, UK – Sygnature Discovery, has been listed in the inaugural Sunday Times BT Business SME Export Track 100. Published in May 2015, Sygnature Discovery has been ranked at number 50, in the league table that ranks Britain’s top 100 private small and medium-sized companies with the fastest growing international sales […]

Nottingham, UK – 12th May 2015 – Sygnature Discovery has today been revealed as a finalist in the Company of Year category of the Nottingham Post Business Awards 2015, This prestigious business award is sponsored by Browne Jacobson and ranks Sygnature Discovery as being amongst the “best of the best” and one of the “icons […]

Discovery of orally-available, potent and selective plasma kallikrein inhibitors for the treatment of diabetic macular edema with KalVista Pharmaceuticals DME is the leading cause of adult visual loss in developed countries and, with limited treatment options, represents a large unmet medical need. DME is caused by disruption of the blood–retinal barrier with increased permeability of […]